BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Drug Development

  MyoKardia Presents Data from Study of Machine Learning Algorithm Intended to Identify Obstructive Hypertrophic Cardiomyopathy Using a Wearable Biosensor

  MyoKardia designed an exploratory digital health substudy as part of the Phase 2 PIONEER-HCM trial of mavacamten (formerly MYK-461) to determine if an optical biosensor, similar to those that monitor heart rate on commercially available fitness trackers, could identify patients with oHCM.

  November 14, 2017

   · 

  5 min read
• Business

  CohBar Announces Third Quarter 2017 Financial Results

  CohBar had cash and investments of $10,342,242 on September 30, 2017, compared to $8,686,420 on December 31, 2016.

  November 14, 2017

   · 

  12 min read
• BioMidwest

  Esperion to Participate in Fireside Chat at the Jefferies 2017 London Healthcare Conference

  Esperion today announced that president and chief executive officer, Tim M. Mayleben, will participate in an analyst-led fireside chat with investors at the Jefferies 2017 London Healthcare Conference in London on Thursday, November 16, 2017 at 1:20 p.m. Greenwich Mean Time / 8:20 a.m. Eastern Time.

  November 14, 2017

   · 

  3 min read
• Business

  Cloud Technology Veteran, Lili Nader, Named CTO of Riffyn

  Ms. Nader is a co-founder of Riffyn and served as the chief software architect of Riffyn’s cloud-based SDE since 2014.

  November 14, 2017

   · 

  2 min read
• Business

  BeiGene Reports Third Quarter 2017 Financial Results

  Cash, Cash Equivalents, and Short-Term Investments were $757.44 million as of September 30, 2017, compared to $407.43 million as of June 30, 2017 and $368.17 million as of December 31, 2016.

  November 14, 2017

   · 

  12 min read
• Business

  Marrone Bio Innovations Reports Third Quarter 2017 Financial Results

  GAAP revenues grew 31% to $14.8 million for the first nine months of 2017, compared to $11.4 million in the same year-ago period.

  November 14, 2017

   · 

  16 min read
• BioMidwest

  Lubrizol LifeSciences and Particle Sciences to Highlight Complex Drug Product Development and Manufacturing at AAPS 2017

  The Lubrizol Corporation’s LifeSciences business announces it will highlight the drug product development and manufacturing capabilities of Particle Sciences Inc. at AAPS 2017.

  November 14, 2017

   · 

  3 min read
• Poor Aggregation Will See ADC Targets Fail or Face Long Delays

  ADC Bio’s leading experts warn that best in class ADCs are being overlooked due to critical aggregation control problems.

  November 14, 2017

   · 

  4 min read
• Pharm Country

  Q Biomed Announces Funding to Technology Partner Mannin Research to Expand Product Pipeline

  Q Biomed congratulates our collaborative research partner and licensor, Mannin Research, on receiving R&D funding from the NRC IRAP to initiate work on a Tie2-activating biologic for the treatment of glaucoma.

  November 14, 2017

   · 

  4 min read
• Biotech Beach

  Janssen R&D’s INVOKANA (canagliflozin) Demonstrates Cardiovascular (CV) Risk Reductions in Type 2 Diabetes Patients With and Without a History of Prior CV Events

  INVOKANA also achieved similar and proportional risk reductions for hospitalization due to heart failure and renal outcomes in each of the primary and secondary prevention groups.

  November 14, 2017

   · 

  15 min read